AUC indicates area under the curve; BC, breast cancer; Dmab, denosumab; EC, epirubicin and cyclophosphamide; nP, nab-paclitaxel; pCR, pathological complete response; SC, subcutaneously; sTILs, stromal tumor-infiltrating lymphocytes; TNBC, triple-negative BC; wk, weekly.